Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wicker

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cancer Letters|November 3, 2024
Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinomaJulianna Korns, Christina A Wicker, Maria Lehn, et al.
Cancers of the Head & Neck|September 18, 2020
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancerSuchin Khanna, Sarah Palackdharry, Logan Roof, et al.
Clinical and Vaccine Immunology : CVI|July 20, 2007
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responsesJennifer Schepp-Berglind, Min Luo, Danher Wang, et al.
Virology|April 21, 2006
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in miceJason A Wicker, Melissa C Whiteman, David W C Beasley, et al.
Vaccine|November 10, 2009
Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virusMelissa C Whiteman, Li Li, Jason A Wicker, et al.
Cancer Letters|January 15, 2021
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma modelsChristina A Wicker, Brian G Hunt, Sunil Krishnan, et al.
Oral Oncology|August 18, 2020
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patientsChristina A Wicker, Vinita Takiar, Rangaswamy Suganya, et al.
Virology|February 9, 2012
Mutational analysis of the West Nile virus NS4B proteinJason A Wicker, Melissa C Whiteman, David W C Beasley, et al.
Inorganic Chemistry|December 19, 2023
Hydrogen Production Using a Nickel Catalyst Combining Redox Activity and Pendent Base EffectsScott A Wicker, Phillips Hutchison, Robert G Musicante, et al.
Schmerz (Berlin, Germany)|April 15, 2017
[Interdisciplinary position paper "Perioperative pain management"]R Likar, W Jaksch, T Aigmüller, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancer Letters|November 3, 2024
Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinomaJulianna Korns, Christina A Wicker, Maria Lehn, et al.
Cancers of the Head & Neck|September 18, 2020
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancerSuchin Khanna, Sarah Palackdharry, Logan Roof, et al.
Clinical and Vaccine Immunology : CVI|July 20, 2007
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responsesJennifer Schepp-Berglind, Min Luo, Danher Wang, et al.
Virology|April 21, 2006
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in miceJason A Wicker, Melissa C Whiteman, David W C Beasley, et al.
Vaccine|November 10, 2009
Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virusMelissa C Whiteman, Li Li, Jason A Wicker, et al.
Cancer Letters|January 15, 2021
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma modelsChristina A Wicker, Brian G Hunt, Sunil Krishnan, et al.
Oral Oncology|August 18, 2020
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patientsChristina A Wicker, Vinita Takiar, Rangaswamy Suganya, et al.
Virology|February 9, 2012
Mutational analysis of the West Nile virus NS4B proteinJason A Wicker, Melissa C Whiteman, David W C Beasley, et al.
Inorganic Chemistry|December 19, 2023
Hydrogen Production Using a Nickel Catalyst Combining Redox Activity and Pendent Base EffectsScott A Wicker, Phillips Hutchison, Robert G Musicante, et al.
Schmerz (Berlin, Germany)|April 15, 2017
[Interdisciplinary position paper "Perioperative pain management"]R Likar, W Jaksch, T Aigmüller, et al.
Pageof 5